Clinical Trial Update: GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial of GLPG0259 in methotrexate-refractory rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GLPG0259
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Galapagos NV | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED